Abstract
The selection process aims sequential enrichment of phage antibody display library in clones that recognize the target of interest or antigen as the library undergoes successive rounds of selection. In this review, selection methods most commonly used for phage display antibody libraries have been comprehensively described.
Keywords: Phage display, antibody, antigen, epitope.
Current Pharmaceutical Design
Title:Methods for Selecting Phage Display Antibody Libraries
Volume: 22 Issue: 43
Author(s): Ricardo Jara-Acevedo, Paula Diez, Maria Gonzalez-Gonzalez, Rosa Maria Degano, Nieves Ibarrola, Rafael Gongora, Alberto Orfao and Manuel Fuentes
Affiliation:
Keywords: Phage display, antibody, antigen, epitope.
Abstract: The selection process aims sequential enrichment of phage antibody display library in clones that recognize the target of interest or antigen as the library undergoes successive rounds of selection. In this review, selection methods most commonly used for phage display antibody libraries have been comprehensively described.
Export Options
About this article
Cite this article as:
Jara-Acevedo Ricardo, Diez Paula, Gonzalez-Gonzalez Maria, Degano Maria Rosa, Ibarrola Nieves, Gongora Rafael, Orfao Alberto and Fuentes Manuel, Methods for Selecting Phage Display Antibody Libraries, Current Pharmaceutical Design 2016; 22 (43) . https://dx.doi.org/10.2174/1381612822666161007153127
DOI https://dx.doi.org/10.2174/1381612822666161007153127 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Stem Cells in Brain Tumorigenesis and their Impact on Therapy
Current Stem Cell Research & Therapy Evaluation of microRNA Stability in Plasma and Serum from Healthy Dogs
MicroRNA Breast Cancer, a Stem Cell Disease
Current Stem Cell Research & Therapy Therapeutic Targeting of Cancers with Loss of PTEN Function
Current Drug Targets N6-methyladenine RNA Modification (m<sup>6</sup>A): An Emerging Regulator of Metabolic Diseases
Current Drug Targets Molecular Signature of HPV-Induced Carcinogenesis: pRb, p53 and Gene Expression Profiling
Current Genomics Predictive Factors of Febrile Neutropenia Induced by Anticancer Chemotherapy in the South of Tunisia
Reviews on Recent Clinical Trials Potential Gene Therapy Strategies for Cancer Stem Cells
Current Gene Therapy Contemporary Role of Endocrine Treatment in Patients with Localized or Locally Advanced Prostate Cancer: A Review
Current Cancer Therapy Reviews Effects of Estrogen in the Brain: Is it a Neuroprotective Agent in Alzheimers Disease?
Current Aging Science Molecules to Selectively Target Receptors for Treatment of Pain and Neurogenic Inflammation
Recent Patents on Inflammation & Allergy Drug Discovery Pharmacological Evaluation of Novel 1,2,4-triazine Derivatives Containing Thiazole Ring against Hepatocellular Carcinoma
Current Bioactive Compounds Formulation Development and Evaluation of Transdermal 5-Fluorouracil Ethosomal Formulation through 2<sup>5-2</sup> Fractional Factorial Design
Drug Delivery Letters The Possible Role of Infertility Drugs in Later Malignancy: A Review
Current Medicinal Chemistry Exploring siRNA Umpired Nanogels: A Tale of Barrier Combating Carrier
Current Pharmaceutical Design Immune Function in Pregnant Women with Affective Disorders
Current Psychiatry Reviews The Synergistic Effects of DNA-Targeted Chemotherapeutics and Histone Deacetylase Inhibitors As Therapeutic Strategies for Cancer Treatment
Current Medicinal Chemistry Activity Based Chemical Proteomics: Profiling Proteases as Drug Targets
Current Drug Discovery Technologies Mitochondrial and Nuclear Genes of Mitochondrial Components in Cancer
Current Genomics NF-κB Signaling Pathway Inhibitors as Anticancer Drug Candidates
Anti-Cancer Agents in Medicinal Chemistry